Evergreen Nephrology – a value-based kidney care platform operating across 24 U.S. states – reported a combination of leadership expansion and strong CMS performance this week. The company appointed industry veteran Eugenia Timm as Chief Operating Officer to oversee day-to-day operations and align clinical and financial performance as it scales.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Timm brings over 15 years of experience leading multi-site, risk-bearing medical groups, most recently managing value-based operations for nearly 190,000 patients at Optum in the Los Angeles South region. Evergreen aims to leverage her background in population health, risk-based operations, and provider network management to support its growing network of more than 1,000 providers.
The company also highlighted its patient-centered engagement strategy, emphasizing high-touch support from engagement specialists who focus on empathy, clear communication, and simplifying complex treatment regimens. This approach is designed to reduce patient overwhelm, improve adherence in chronic kidney disease care, and complement nephrologists’ efforts.
Evergreen stressed the importance of team-based care, including coordinated clinical support and access to social and emotional resources for patients. Management positions these services as tools to improve education, clarify medications, manage symptoms, and ultimately reduce avoidable hospitalizations under risk-based contracts.
On the physician side, Evergreen promoted its involvement in a Healthcare Innovation Q&A featuring chief development and strategy officer Scott Lloyd and Colorado Kidney Care’s Dr. Britt Newsome. The discussion underscored collaboration, shared accountability, aligned incentives, and interdisciplinary support teams as central to engaging nephrologists in value-based models.
The company further showcased its Evergreen Physicians Leadership Council, which allows network nephrologists to help shape programs that drive provider alignment and patient outcomes. Its presence and hosted events at the RPA 2026 conference in Atlanta signaled continued investment in strengthening relationships and referral networks with kidney specialists nationwide.
Operationally, Evergreen reported strong results in the CMS Kidney Care Choices program, generating over $40 million in Medicare savings and ranking second nationally among Kidney Contracting Entities in net savings. The platform achieved roughly $225 in Medicare savings per patient per month and supported more than $35 million in quality-linked performance payments.
Key clinical metrics included a 58% optimal start rate for kidney replacement therapy, delayed progression to kidney failure in 35% of a monitored stage 4 chronic kidney disease cohort, and a transplant access rate 25% above the national average. These outcomes suggest that Evergreen’s early intervention and coordinated care approach can align quality improvements with predictable savings in value-based kidney care.
Taken together, the COO appointment, strong CMS results, and reinforced patient and physician engagement strategies indicate that Evergreen Nephrology is consolidating its position in risk-bearing kidney care. The company’s execution this week points to a focused effort on scalable operations and measurable performance as it continues to expand its value-based platform.